Fluispotter ApS

Q: What is the CVR number of Fluispotter ApS?

Fluispotter ApS is registered with CVR / Virk under CVR 44364646.

Q: What is the gross profit of Fluispotter ApS?

Fluispotter ApS reported a gross profit of -DKK 262.0k in 2025.

Q: How many employees does Fluispotter ApS have?

Fluispotter ApS employs 2 people as of the latest annual report.

Q: Where is Fluispotter ApS headquartered?

Fluispotter ApS's registered address is Olgasvej 42.

APSActiveAdvertising protection

CVR 44364646Olgasvej 42, 2950 VedbækResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2023 · 2 years old2 employees

Overview

Fluispotter ApS is a Danish APS based in Vedbæk, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2023, the company has 2 employees and reported a gross profit of -DKK 262.0k in its latest annual filing.

Gross profit 2025

-0.3M DKK

−138% vs 2024

EBITDA margin (of gross profit)

224.3 %

−97% vs 2024

Net profit 2025

-1.3M DKK

-40% vs 2024

Key ratios

See full ratios →

-52.3 %

Very weak

Among the 10% lowest rated companies in the industry

20242025

0.1×

Very weak

Among the 10% lowest rated companies in the industry

20242025

-31.1 %

Very weak

Among the 20% lowest rated companies in the industry

20242025

EBITDA — year on year

DKK thousands

Key figures

Annual report 2025

Gross profit	-0.3M DKK	-138%
EBITDA	-0.6M DKK	-97%
Net profit	-1.3M DKK	-40%
Total assets	4M DKK	-14%
Equity	-2.1M DKK	-147%
Employees	2	—

Contact

Address

Olgasvej 42, 2950 Vedbæk

Advertising protection

Active — opted out of marketing use

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Financial development

In its most recent annual report (2025), Fluispotter ApS reported a gross profit of -DKK 262.0k, a decrease of 138% on the year before. The figures on this page draw on 2 annual filings covering 2024 to 2025. The bottom line showed a net loss of DKK 1.3m.

At the end of 2025, current assets covered short-term debt 0.1 times. Fluispotter ApS is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.

Financials

Gross profit

DKK thousands

EBITDA

DKK thousands

Income statement

DKK thousands

Item	2025	2024
Gross profit	-262	681
Staff expenses	-326	-979
EBITDA	-588	-298
Depreciation & amort.	-525	-525
EBIT	-1,113	-823
Net financials	-153	-72
Profit before tax	-1,266	-895
Tax	-10	-0
Net profit	-1,256	-895

Get a credit rating – not just the numbers

Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.

See the credit rating

Balance sheet

DKK thousands

Item	2025	2024
Total assets	4,039	4,676
Equity	-2,111	-855
Long-term debt	5,000	5,000
Short-term debt	1,150	531
Total debt	6,150	5,531

Financial ratios

5-year trend

EBITDA margin (of gross profit)

<−999 %

20242025

Equity ratio

-52.3 %

Very weak

Among the 10% lowest rated companies in the industry

20242025

Return on equity

—

20242025

Net profit margin (of gross profit)

<−999 %

20242025

Asset turnover (of gross profit)

-0.06×

20242025

Debt / equity

—

20242025

Sector performance

17 of 28 ratios graded

28 financial ratios from the latest filing, each graded against companies in the same industry.

Profitability

Return on assets (ROA)Very weak

Among the 20% lowest rated companies in the industry

Net profit as a percentage of total assets — the return generated on the capital employed.

Basic earning power (BEP)Very weak

Among the 20% lowest rated companies in the industry

EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.

Capacity ratioVery weak

Among the 10% lowest rated companies in the industry

Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.

Gross marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.

Operating marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.

Net profit marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The profit for the year as a share of revenue — the company's ability to turn revenue into profit.

Return on equity (ROE)Not rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Net profit as a percentage of equity — the return the owners earned on their invested capital this year.

Return on net assets (RONA)Not rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.

Liquidity

Current ratioVery weak

Among the 10% lowest rated companies in the industry

Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.

Quick ratioVery weak

Among the 10% lowest rated companies in the industry

Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.

Cash ratioWeak

Among the 30% lowest rated companies in the industry

Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.

Fixed assets to long-term capitalVery weak

Among the 10% lowest rated companies in the industry

Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.

Cash conversion ratioWeak

Among the 30% lowest rated companies in the industry

Cash flow relative to profit — the ability to convert reported profits into accessible cash.

Current assets to equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.

Debt & solvency

Solidity ratioVery weak

Among the 10% lowest rated companies in the industry

Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.

Debt ratioVery weak

Among the 20% lowest rated companies in the industry

Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.

Income to debtWeak

Among the 30% lowest rated companies in the industry

Profit relative to debt — the ability to create earnings while operating with debt.

EBITDA to debtWeak

Among the 30% lowest rated companies in the industry

EBITDA relative to debt — how much operating earnings are available to service the debt.

Interest coverageWeak

Among the 30% lowest rated companies in the industry

The ability to pay the interest on the company's debt out of its earnings.

Interest rate on debtWeak

Among the 40% lowest rated companies in the industry

Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.

Interest marginVery weak

Among the 20% lowest rated companies in the industry

The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.

Debt to equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.

Liabilities to equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.

Efficiency & development

Equity to contributed capitalVery weak

Among the 10% lowest rated companies in the industry

Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.

One-year change in debtWeak

Among the 40% lowest rated companies in the industry

The size of this year's increase or decrease in the company's debt.

Asset turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to total assets — the ability to generate revenue from the asset base.

Inventory turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.

One-year change in equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The size of this year's increase or decrease in the company's equity.

Annual reports & filings

Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-12 – 2024-12-31
View PDF

People & ownership

Management

Actively employed in the business

Name	Role	Member since
Current (2)
IJ Ian Jørgensen Management	Management	2023
SV Sten Velschow Management	Management	2023

Board of directors

Non-executive oversight

No data on file.

Shareholders

Active legal owners

Shareholder	Type	Ownership	Votes	Registered
Compact Biomedical ApS	Company	50–66.65%	50–66.65%	2023
RantChant ApS	Company	33.33–49.99%	33.33–49.99%	2023
Emagino ApS	Company	10–14.99%	10–14.99%	2023
Majoha ApS	Company	10–14.99%	10%	2023